Cite

HARVARD Citation

    Stathis, A. et al. (n.d.). 340 A phase I study of the smoothened (SMO) antagonist LDE225 in combination with paclitaxel in patients with advanced solid tumors. European journal of cancer. pp. S67-. [Online]. 
  
Back to record